Awakn Life Sciences announced it raised $130,000 in an initial filing from an offering of $285,000
09/28/22, 9:21 PM
Location
toronto
Money raised
$130,000
Industry
other
Round Type
pre-seed
Company Info
Location
301-217 queen st west
toronto, ontario, canada
Additional Info
Awakn Life Sciences (NEO: AWKN) (OTCQB: AWKNF) is a biotechnology company researching, developing, and delivering revolutionary therapeutics to treat addiction. Awakn's team consists of renowned research experts and world leading chemists, scientists, psychiatrists, and psychologists. Addiction is one of the biggest unmet medical needs of our time, affecting over 20% of the global population and is an industry valued at over $100bn per annum. Awakn is disrupting this underperforming industry by rapidly advancing the next generation of psychedelic drugs and therapies to be used in combination, through preclinical research and clinical stage trials.